Chronic Diseases and Health Promotion – www.who.int/chp/enwww.who.int/chp/en Global Alliance against Chronic Respiratory Diseases - www.who.int/respiratory/gardwww.who.int/respiratory/gard.

Slides:

Advertisements

Similar presentations

© Global Initiative for Chronic Obstructive Lung Disease (GOLD)

Advertisements

GARD Global Alliance against Chronic Respiratory Diseases WHO J Bousquet, R Dahl, N Khaltaev, HJ Bekedam.

Date: Saturday, April 28, 2007 Presented by: Carl C. Booberg Executive Director of the American Thoracic Society.

1 LeTourneau University Tim Ochran, MS, DABR, Associate Professor of Radiation Oncology, UTHSCT January 26, 2011.

People want care. Where it comes from is secondary Breda Flood EFA President Athens, 24th May

Turkish Thoracic Society: Who are we? Turkish Thoracic Society is a national, professional and scientific non-profit organization of specialists in Respiratory.

Research Grant and Funding Opportunities in the Area of Disability Research Trevor R. Parmenter AM Foundation Professor of Developmental Disability Foundation.

GARD - Country Initiatives BRAZIL Alvaro A. Cruz, M.D. Associate Professor of Universidade Federal da Bahia Scientist of CNPq - National Research Council.

Asthma What is Asthma ? V1.0 1997 Merck & ..

Martina Vasakova Emilia Kopecka Jitka Soukupova Thomayer University Hospital Prague Tuberculosis in the Czech Republic. MDR- TB Unit of the Czech Republic.

WHAT YOU NEED TO KNOW ABOUT BLOOD CLOTS VTE Venous Thromboembolism Toolkit for Health Professionals.

Report to IPCRG Family Physician Airways Group of Canada.

Statewide campaign to educate patients and physicians on important health topics: Choosing Wisely® ER is for Emergencies campaign Palliative care and end.

How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.

International Primary Care Respiratory Group working locally, collaborating globally.

National Asthma Educator Examination National Asthma Educator Examination.

1 Ho Chi Minh City, Vietnam, July 27, 2008 Daniel Navid, Chief Executive Officer International Osteoporosis Foundation Osteoporosis and the role of IOF.

Respiratory Care Understanding the Organizations that Serve Our Profession.

Launch of Global Alliance of Chronic Respiratory Diseases (GARD) Participants Organizations of GARD Eva Mantzouranis MD Chronic Respiratory.

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases -

European Federation of Allergy and Airways Diseases Patients Associations Updates on Innovative Research for Allergy and Respiratory Disease in the European.

Targeting the respiratory nurse in primary care Practical and informative editorial Easy-to-read format Published quarterly The only journal specifically.

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases -

Presentation of EFA and Most Recent Activities David Brennan EU Policy and Programme Assistant

WP 4.1.Clinical Field Survey SINPHONIE Project kick-off meeting November, REC Conference Center, Szentendre Hungary Peter Rudnai National Institute.

Burden of chronic diseases Giovanni Viegi, MD. Director of Research, Italian National Research Council. Head, Pulmonary Environmental Epidemiology Unit,

GARD PROJECT IN CABO VERDE José Rosado Pinto GARD WHO Meeting Beijing March 2005 Serviço de Imunoalergologia, Hospital de Dona Estefânia Lisboa,

Report from GARD secretariat Nikolai Khaltaev, MD, PhD March 2006, GARD General Meeting, Beijing, China.

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases -

What China have done and will do since the GARD Launch Meeting held on March 28, 2006?

Chronic diseases of the airways Contents and tools for productive interactions between empowered patients and proactive professionals HMSP-IDSIM/SIM/0018/2009.

The PRIME Study Dr. Komalkirti Apte

ABOM Partner Organizations

Why buildings are key to achieve a better health in the EU?

How does teamwork improve value. Dr Nils E

The Project – EuroHeart II

Pharmacologic rationale for treating allergic and nonallergic rhinitis

Asthma Phenotypes Defined From Parameters Obtained During Recovery From a Hospital-Treated Exacerbation Rihuang Qiu, MD, Jiaxing Xie, MD, PhD, Kian Fan.

Global Alliance for Patient Access (GAfPA) Miami, 26 May 2018

ČIPA – Czech Initiative for Asthma

Prevalence of true-positive, false-negative and false-positive cases of chronic obstructive pulmonary disease identified with the fixed-limit Global Initiative.

Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation Nicholas J. Gross, MD,

Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Forward from European Parliament President Jerzy Buzek

Selected activities carried out by the Polish Federation of Asthma, Allergy and COPD Patients’ Associations Artur BADYDA.

A white elephant or the elephant in the room

Level of physical activity by Global Initiative for Obstructive Lung Disease (GOLD) stage, BODE (body mass index, FEV1 for airflow obstruction, dyspnoea,

Occurrence of morning symptoms

National burden of antibiotic use for adult rhinosinusitis

Smoking cessation rate as point prevalence quit rate from year 1 to 5 in the Lung Health Study with 5,587 chronic obstructive pulmonary disease patients.

A review of the current guidelines for allergic rhinitis and asthma

Countries and nationalities

3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).

A burning need to redefine airways disease: Biomass smoke exposure identified as a unique risk factor for asthma–chronic obstructive pulmonary disease.

A family-based pulmonary rehabilitation (PR) programme enhanced the coping resources of the families of chronic obstructive pulmonary disease patients.

Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with Common Variable Immunodeficiency Phil Lieberman, MD, John Routes, MD The Journal.

E. Rand Sutherland, MD, MPH Journal of Allergy and Clinical Immunology

American Academy of Allergy, Asthma & Immunology

Screening test accuracy of the final risk score at a threshold of ≥2

Schematic diagram of the shared subgroups between asthma and chronic obstructive pulmonary disease (COPD). Schematic diagram of the shared subgroups between.

Correlation between inspiratory capacity (IC)/total lung capacity (TLC) ratio and oxygen pulse at peak exercise in chronic obstructive pulmonary disease.

Clinical findings in patients with chronic obstructive pulmonary disease according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD)

Prevalence of chronic obstructive pulmonary disease (COPD) defined by different criteria by region. The dark grey bar represents ‘symptom-based COPD’,

Advances in pediatric asthma in 2007

Asthma, COPD, and overlap in a national cohort: ACO on a gradient

Chronic obstructive pulmonary disease (COPD) prevalence (postbronchodilator FEV1/FVC (forced expiratory volume in 1 s/forced vital capacity)

Stacked bar charts for key predictor variables (representativeness of SLS COPD). Stacked bar charts for key predictor variables (representativeness of.

E. Rand Sutherland, MD, MPH, Barry J

Presentation transcript:

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases - Nikolai Khaltaev GARD Meeting ERS Congress 3 September, Munich Status of GARD Participants and New Applicants

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases - Overview Participants

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases - Second Year DA Signed AAAAI American Academy of Allergy, Asthma and Immunology (May 2006) ACAAI American College of Allergy, Asthma and Immunology (May 2006) AIMAR Interdisciplinary Association for Research in Lung Disease (July 2006) ARIA Allergic Rhinitis and its impact on Asthma (November 2005) CNR - INMM Italian National Research Council - Institute of Neurobiology and Molecular Medicine (July 2006) EAACI European Academy of Allergy and Clinical Immunology (May 2006) ECARF European Centre for Allergy Research Foundation (May 2006) ERS European Respiratory Society (May 2006) FILHA Finnish Lung Health Association (May 2006) FIRS Forum of the International Respiratory Societies (May 2006) GA2LEN Global Allergy and Asthma European Network (May 2006) GINA Global Initiative for Asthma (May 2006) ICC International Coalition for COPD (Jan 2006) WAO World Allergy Organization (Jan 2006) WONCA World Organization of Family Doctors (Jan 2006) Red: no money received yet

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases - Second Year DA in the process to be renewed AAAF Asian Allergy and Asthma Foundation ALAT Latin American Thoracic Society APAACI Asia Pacific Association of Allergology and Clinical Immunology APSR Asian Pacific Society of Respirology ATS American Thoracic Society DU-WCC Dokkyo University WHO Collaborating Centre EFA European Federation of Allergy and Airways Diseases Patients' Associations FEMTEC World Federation of Hydrotherapy and Climatotherapy GOLD Global Initiative for Chronic Obstructive Pulmonary Disease GU-WCC Ghent University WHO Collaborating Centre INTERASMA International Association of Asthmology KAAF Korea Asthma Allergy Foundation NHLBI National Hearth Lung and Blood Institute, USA RSP Russian Society of Pulmonologists SFAIC Société Française d’Allergologie et d’Immunologie Clinique SPAIC Portuguese Society of Allergology and Clinical Immunology SPLF Société de Pneumologie de Langue française TTS Turkish Thoracic Society

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases - First DA signed AAA Asthma and Allergy Association, France (Jan 2006) IPCRG International Primary Care Respiratory Group (Jan 2006) PSA Polish Society of Allergology (April 2006) TNSACI Turkish National Society of Allergy and Clinical Immunology (June 2006)

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases - Participants with no voluntary contributions expected DHLA Danish Lung Health Association IPRAIS International Pediatric Respiratory and Allergies Immunological Societies KTL National Public Health Institute, Finland The Union International Union Against Tubercolosis and Lung Diseases

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases - Drop out IRCCS San Raffaele, Italy

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases - Overview New Applicants

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases - Applicants offering a voluntary financial contribution BTS Belgian Thoracic Society EFH Education for Health, England GRA Georgian Respiratory Association IFOS International Federation of Oto-Rhino-Laryngolocial Societies JSA Japanese Society of Allergology SAAAIC Société Algérienne d'Asthmologie, d'Allergologie et d'Immunologie Clinique SIMER Italian Society of Respiratory Medicine SLAI Société Libanaise d’Allergie et d’Immunologie TSTM Tunisian Society of Thoracic Medicine

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases - Applicants not offering a financial voluntary contribution CIPA Czech Initiative for Asthma IRS International Rhinologic Society PATS Pan African Thoracic Society Tishreen University - Faculty of Medicine, Syria

Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases - Still to take a decision on the financial voluntary contribution BSM Bulgarian Society of Medicine CRF Chest Research Foundation, India MSTM Macedonian Society of Thoracic Medicine YAAC Yugoslav Association for Asthma and COPD